Autor: |
Azzania Fibriani, Audrey Angelina Putri Taharuddin, Rebecca Stephanie, Nicholas Yamahoki, Jessica Laurelia, Popi Hadi Wisnuwardhani, Dian Fitria Agustiyanti, Marissa Angelina, Yana Rubiyana, Ratih Asmana Ningrum, Andri Wardiana, Ferry Iskandar, Fitri Aulia Permatasari, Ernawati Arifin Giri-Rachman |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
Heliyon, Vol 9, Iss 9, Pp e20089- (2023) |
Druh dokumentu: |
article |
ISSN: |
2405-8440 |
DOI: |
10.1016/j.heliyon.2023.e20089 |
Popis: |
Even entering the third year of the COVID-19 pandemic, only a small number of COVID-19 antiviral drugs are approved. Curcumin has previously shown antiviral activity against SARS-CoV-2 nucleocapsid, but its poor bioavailability limits its clinical uses. Utilizing nanotechnology structures, curcumin-derived carbon-dots (cur-CDs) were synthesized to increase low bioavailability of curcumin. In-silico analyses were performed using molecular docking, inhibition of SARS-CoV-2 nucleocapsid C-terminal domain (N-CTD) and antiviral activity were assessed in dimer-based screening system (DBSS) and in vitro respectively. Curcumin bound with the N-CTD at ΔG = −7.6 kcal/mol, however modifications into cur-CDs significantly improved the binding affinity and %interaction. Cur-CDs also significantly increased protection against SARS-CoV-2 in both DBSS and in vitro at MOI = 0.1. This study demonstrated the effect of post-infection treatment of curcumin and novel curcumin-derived carbon-dots on SARS-CoV-2 N-CTD dimerization. Further investigation on pre-infection and in-vivo treatment of curcumin and cur-CDs are required for a comprehensive understanding on the carbon-dots enhanced antiviral activity of curcumin against SARS-CoV-2. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|